Objective Both variations in the interleukin-10 (IL10) gene and environmental factors are thought to influence inflammation and gastric carcinogenesis. Therefore, we investigated the associations between IL10 polymorphisms, Helicobacter pylori (H. pylori) infection, and smoking in noncardia gastric carcinogenesis in Koreans. Methods We genotyped three promoter polymorphisms (-1082A>G, -819T>C, and -592 A>C) of IL10 in a case-control study of 495 noncardia gastric cancer patients and 495 sex- and age-matched healthy controls. Multiple logistic regression models were used to detect the effects of IL10 polymorphisms, H. pylori infection, and smoking on the risk of gastric cancer, which was stratified by the histological type of gastric cancer. Results The IL10-819C and -592C alleles were found to have complete linkage disequilibrium, and all three IL10 polymorphisms were associated with an increased risk of intestinal-type noncardia gastric cancer. These associations were observed only in H. pylori-positive subjects and current smokers. A statistically significant interaction between the IL10-592 genotype and H. pylori infection on the risk of intestinal-type gastric cancer was observed (P for interaction = 0.047). In addition, H. pylori-positive smokers who were carriers of either the IL10-1082G (OR [95% CI] = 17.76 [6.17？51.06]) or the -592C (OR [95% CI] = 8.37 [2.79？25.16]) allele had an increased risk of intestinal-type gastric cancer compared to H. pylori-negative nonsmokers homozygous for IL10-1082A and -592A, respectively. The interaction between the IL10-1082 polymorphism and the combined effects of H. pylori infection and smoking tended towards significance (P for interaction = 0.080). Conclusions Inflammation-related genetic variants may interact with H. pylori infection and smoking to increase the risk of noncardia gastric cancer, particularly the intestinal-type. These findings may be helpful in identifying individuals at an increased risk for developing noncardia gastric cancer.
References
[1]
Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69–90.
Fox JG, Wang TC (2007) Inflammation, atrophy, and gastric cancer. J Clin Invest 117: 60–69.
[4]
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860–867.
[5]
Wu MS, Chen CJ, Lin JT (2005) Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev 14: 1878–1882.
Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, et al. (1997) Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41: 442–451.
Kang JM, Kim N, Lee DH, Park JH, Lee MK, et al. (2009) The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol 43: 420–428.
[10]
De Vita F, Orditura M, Galizia G, Romano C, Infusino S, et al. (1999) Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer 86: 1936–1943.
[11]
Lopez P, Gutierrez C, Suarez A (2010) IL-10 and TNFalpha genotypes in SLE. J Biomed Biotechnol. doi:10.1155/2010/838390.
[12]
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, et al. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24: 1–8.
[13]
Suarez A, Castro P, Alonso R, Mozo L, Gutierrez C (2003) Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 75: 711–717.
[14]
El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, et al. (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124: 1193–1201.
[15]
Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, et al. (2007) Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 22: 1443–1449.
[16]
Levitzky YS, Guo CY, Rong J, Larson MG, Walter RE, et al. (2008) Relation of smoking status to a panel of inflammatory markers: the framingham offspring. Atherosclerosis 201: 217–224.
[17]
Garcia-Gonzalez MA, Lanas A, Quintero E, Nicolas D, Parra-Blanco A, et al. (2007) Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol 102: 1878–1892.
[18]
Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, et al. (2003) Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 104: 617–623.
[19]
Lee JY, Kim HY, Kim KH, Kim SM, Jang MK, et al. (2005) Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 225: 207–214.
[20]
Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31–49.
[21]
Zhuang W, Wu XT, Zhou Y, Liu L, Liu GJ, et al. (2010) Interleukin10 -592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies. Dig Dis Sci 55: 1525–1532.
[22]
Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, et al. (2008) Interleukin-10-1082 promoter polymorphism associated with gastric cancer among Asians. Eur J Cancer 44: 2648–2654.
[23]
Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, et al. (2005) Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 29: 141–152.
[24]
Pyo CW, Hur SS, Kim YK, Choi HB, Hong YS, et al. (2003) Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-gamma genes in the Korean population. Hum Immunol 64: 979–989.
[25]
Bodger K, Wyatt JI, Heatley RV (1997) Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut 40: 739–744.
[26]
Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, et al. (2004) Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53: 1082–1089.
[27]
Szkaradkiewicz A, Karpinski TM, Drews M, Borejsza-Wysocki M, Majewski P, et al. (2010) Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer. J Biomed Biotechnol. doi:10.1155/2010/901564.
[28]
Mege JL, Meghari S, Honstettre A, Capo C, Raoult D (2006) The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis 6: 557–569.
[29]
Moy KA, Fan Y, Wang R, Gao YT, Yu MC, et al. (2010) Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev 19: 2287–2297.
[30]
Shikata K, Doi Y, Yonemoto K, Arima H, Ninomiya T, et al. (2008) Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study. Am J Epidemiol 168: 1409–1415.
[31]
Brenner H, Arndt V, Bode G, Stegmaier C, Ziegler H, et al. (2002) Risk of gastric cancer among smokers infected with Helicobacter pylori. Int J Cancer 98: 446–449.
[32]
Shimoyama T, Everett SM, Fukuda S, Axon AT, Dixon MF, et al. (2001) Influence of smoking and alcohol on gastric chemokine mRNA expression in patients with Helicobacter pylori infection. J Clin Pathol 54: 332–334.
[33]
Iwata F, Zhang XY, Leung FW (1995) Aggravation of gastric mucosal lesions in rat stomach by tobacco cigarette smoke. Dig Dis Sci 40: 1118–1124.
[34]
Sipponen P, Correa P (2002) Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5: 213–219.
[35]
Yim JY, Kim N, Choi SH, Kim YS, Cho KR, et al. (2007) Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 12: 333–340.
[36]
Ko KP, Park SK, Cho LY, Gwack J, Yang JJ, et al. (2009) Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr 139: 1008–1012.
[37]
Hamilton SR, Aaltonen LA (2000) Pathology and genetics of tumours of the digestive system. World Health Organization classification of tumours. Lyon: IARC Press.
[38]
Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS (2009) Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev 18: 1945–1952.
[39]
Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, et al. (2006) Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 98: 1445–1452.
[40]
Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49: 347–353.
[41]
Epplein M, Nomura AM, Hankin JH, Blaser MJ, Perez-Perez G, et al. (2008) Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case-control study in Hawaii. Cancer Causes Control 19: 869–877.
[42]
Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52: 6735–6740.
[43]
Persson C, Jia Y, Pettersson H, Dillner J, Nyren O, Ye W (2011) H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship? PLoS One 6: e17404.
[44]
Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH (2003) Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125: 1636–1644.
[45]
Kim CG, Choi IJ, Lee JY, Cho SJ, Nam BH, et al. (2009) Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer. J Gastroenterol Hepatol 24: 469–474.
[46]
Chang YW, Han YS, Lee DK, Kim HJ, Lim HS, et al. (2002) Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Int J Cancer 101: 469–474.
